T lymphocytes
Showing 1 - 25 of >10,000
Granuloma, Aluminum Allergy Trial in Hellerup (Aluminum, Tetanus toxoid)
Completed
- Granuloma
- Aluminum Allergy
- Aluminum
- Tetanus toxoid
-
Hellerup, DenmarkNational Allergy Research Centre, Gentofte Hospital
Nov 8, 2023
Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)
Recruiting
- Gastric Cancer
- +6 more
- CEA-targeted CAR-T cells
-
Taiyuan, Shanxi, China
- +1 more
Aug 24, 2023
Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)
Recruiting
- Gastric Cancer
- +7 more
- CEA-targeted CAR-T cells
-
Wuhu, Anhui, ChinaThe First Affiliated Hospital of Wannan Medical College
Nov 9, 2023
Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)
Recruiting
- Adenovirus Infection
- Adenovirus Specific T lymphocytes
-
Columbus, OhioNationwide Children's Hospital
Sep 1, 2022
Acute Myeloid Leukemia Trial in Kunming (Anti-CLL1 CART cells)
Recruiting
- Acute Myeloid Leukemia
- Anti-CLL1 CART cells
-
Kunming, Yunnan, ChinaNo.212 Daguan Road, Xishan District
Nov 23, 2022
Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))
Recruiting
- Solid Tumor
- Tumor-associated antigen-specific T cell (TAA-T)
-
Washington, District of ColumbiaChildren's National Hospital
Oct 24, 2022
NSCLC Trial in Yichang (Sindillimab)
Completed
- Non-small Cell Lung Cancer
-
Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
Mar 29, 2023
CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection
Recruiting
- Nephrotic Syndrome
- +2 more
- The study is an observational study without intervention
-
Zhuhai, Guangdong, Chinathe fifth affiliated hospital of SUN YAT-SEN university
Nov 20, 2022
Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)
Recruiting
- Multiple Myeloma
- TAA-specific CTLs
- TAA-specific CTLs- fixed dose
-
Houston, TexasHouston Methodist Hospital
Nov 11, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)
Active, not recruiting
- Acute Lymphocytic Leukemia
- Lymphoma
- Biological/Genetically Modified T cells
- Cyclophosphamide-based chemotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)
Not yet recruiting
- Adenovirus
- +2 more
- Specific T- Lymphocytes
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Sep 8, 2023
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)
Recruiting
- Hodgkins Lymphoma
- Non Hodgkins Lymphoma
- TAA-specific CTLs
-
Houston, TexasTexas Children's Hospital
Jul 14, 2022
Severe COVID-19 Trial in Thessaloniki (Coronavirus-2-specific T cells, standard of care (SOC))
Recruiting
- Severe COVID-19
- Coronavirus-2-specific T cells
- standard of care (SOC)
-
Thessaloniki, Greece
- +1 more
Nov 22, 2022
Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Epstein-Barr Virus Infections
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Covid19 Trial in Philadelphia (Cytotoxic T Lymphocytes)
Active, not recruiting
- Covid19
- Cytotoxic T Lymphocytes
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 15, 2022
Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Adenovirus
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +8 more
Sep 27, 2022
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)
Recruiting
- SLE (Systemic Lupus)
- +4 more
- CD19 targeted CAR-T cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Sep 25, 2023
COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)
Active, not recruiting
- COL6A3 Positive
- +3 more
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Neutrophils and Circulating Platelets in Correlation With
Recruiting
- NAFLD- Non Alcoholic Fatty Liver Disease
- Data collection
-
L'Aquila, Italy/L'Aquila, ItalyClara Balsano
Apr 27, 2022
Opportunistic Fungal Infection, Opportunistic Viral Infection, Bone Marrow Transplant Infection Trial in Patra, Thessaloníki
Recruiting
- Opportunistic Fungal Infection
- +2 more
- Pentavalent-specific T cells (penta-STs)
-
Patra, Greece
- +1 more
Jul 26, 2022
Rheumatoid Arthritis, Swelling Joint, Joint Fluid Trial in Montpellier (Exploratory synovial fluid analysis)
Recruiting
- Rheumatoid Arthritis
- +3 more
- Exploratory synovial fluid analysis
-
Montpellier, FranceLapeyronie Hospital
Jan 12, 2022